Jacobs IJ - Search Results

1

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women.

Gentry-Maharaj A, Blyuss O, Ryan A, Burnell M, Karpinskyj C, Gunu R, Kalsi JK, Dawnay A, Marino IP, Manchanda R, Lu K, Yang WL, Timms JF, Parmar M, Skates SJ, Bast RC Jr, Jacobs IJ, Zaikin A, Menon U. Gentry-Maharaj A, et al. Among authors: jacobs ij. Cancers (Basel). 2020 Jul 17;12(7):1931. doi: 10.3390/cancers12071931. Cancers (Basel). 2020. PMID: 32708856 Free PMC article.

2

Strategies for improving the specificity of screening for ovarian cancer with tumor-associated antigens CA 125, CA 15-3, and TAG 72.3.

Jacobs IJ, Oram DH, Bast RC Jr. Jacobs IJ, et al. Obstet Gynecol. 1992 Sep;80(3 Pt 1):396-9. Obstet Gynecol. 1992. PMID: 1495694

3

Differential diagnosis of ovarian cancer with tumour markers CA 125, CA 15-3 and TAG 72.3.

Jacobs IJ, Rivera H, Oram DH, Bast RC Jr. Jacobs IJ, et al. Br J Obstet Gynaecol. 1993 Dec;100(12):1120-4. doi: 10.1111/j.1471-0528.1993.tb15177.x. Br J Obstet Gynaecol. 1993. PMID: 8297846

4

Elevation of multiple serum markers in patients with stage I ovarian cancer.

Woolas RP, Xu FJ, Jacobs IJ, Yu YH, Daly L, Berchuck A, Soper JT, Clarke-Pearson DL, Oram DH, Bast RC Jr. Woolas RP, et al. Among authors: jacobs ij. J Natl Cancer Inst. 1993 Nov 3;85(21):1748-51. doi: 10.1093/jnci/85.21.1748. J Natl Cancer Inst. 1993. PMID: 8411259

5

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Among authors: jacobs ij. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

6

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Jacobs IJ, Skates S, Davies AP, Woolas RP, Jeyerajah A, Weidemann P, Sibley K, Oram DH. Jacobs IJ, et al. BMJ. 1996 Nov 30;313(7069):1355-8. doi: 10.1136/bmj.313.7069.1355. BMJ. 1996. PMID: 8956699 Free PMC article. Clinical Trial.

7

No evidence exists for methylation inactivation of the p16 tumor suppressor gene in ovarian carcinogenesis.

Ryan A, Al-Jehani RM, Mulligan KT, Jacobs IJ. Ryan A, et al. Among authors: jacobs ij. Gynecol Oncol. 1998 Jan;68(1):14-7. doi: 10.1006/gyno.1997.4881. Gynecol Oncol. 1998. PMID: 9454653

8

p53 codon 72 polymorphism and risk of cervical cancer in UK.

Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA, Jacobs IJ. Rosenthal AN, et al. Among authors: jacobs ij. Lancet. 1998 Sep 12;352(9131):871-2. doi: 10.1016/S0140-6736(98)07357-7. Lancet. 1998. PMID: 9742979

9

Screening for ovarian cancer: a pilot randomised controlled trial.

Jacobs IJ, Skates SJ, MacDonald N, Menon U, Rosenthal AN, Davies AP, Woolas R, Jeyarajah AR, Sibley K, Lowe DG, Oram DH. Jacobs IJ, et al. Lancet. 1999 Apr 10;353(9160):1207-10. doi: 10.1016/S0140-6736(98)10261-1. Lancet. 1999. PMID: 10217079 Clinical Trial.

10

Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.

Jeyarajah AR, Ind TE, Skates S, Oram DH, Jacobs IJ. Jeyarajah AR, et al. Among authors: jacobs ij. Cancer. 1999 May 1;85(9):2068-72. doi: 10.1002/(sici)1097-0142(19990501)85:9<2068::aid-cncr25>3.0.co;2-8. Cancer. 1999. PMID: 10223249 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

266 results

Search Page

Filters